Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine

General Physiology and Biophysics

Volumn 19, Issue 4, 2000, Pages 381-392

  Waczulikova I ^a   Sikurova L ^a   Carsky J ^b   Strbova L ^c   Krahulec, B ^c  

^a Physics and Informatics   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Erythrocyte membranes; Fluorescence anisotropy; Glycation; Membrane fluidity; Resorcylidene aminoguanidine

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; AMINOGUANIDINE; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; RESORCYLIDENE AMINOGUANIDINE; UNCLASSIFIED DRUG;

ANISOTROPY; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL MEMBRANE FLUIDITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CROSS LINKING; ERYTHROCYTE MEMBRANE; FLUORESCENCE; GLYCATION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE MEMBRANE; FLUORESCENCE POLARIZATION; GUANIDINES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS; MEMBRANE FLUIDITY; REFERENCE VALUES; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 0034445418     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Baba Y., Kai M., Kamada T., Setoyama S., Otsuji S. (1979): Higher levels of erythrocyte membrane microviscosity in diabetes. Diabetes 28, 1138-1140
2. Baynes J. W. (1996): The role of oxidation in the Maillard reaction in vivo. In: The Maillard Reaction: Consequences for the Chemical and Life Sciences (Ed. R. Ikan), pp. 55-72, John Wiley Sons Ltd
3. + monovalent cation exchanger in the human red blood cell membrane: effects of transport inhibitors. Gen. Physiol. Biophys. 18, 119-137
4. Brewer G. J. (Ed.) (1975): Erythrocyte Structure and Function., pp. 343-378, 467-506, 535-557, Alan R. Liss, Inc., New York
5. Brownlee M. (1991): Glycosylation products as toxic mediators of diabetic complications. Annu. Rev. Med. 42, 159-166
6. Brownlee M., Vlassara H., Cerami A. (1984): Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Inter. Med. 101, 527-537
7. Brownlee M., Vlassara H., Kooney A., Ulrich P., Cerami A. (1986): Aminoguanidine prevents diabetes induced arterial wall protein cross-linking. Science, 232, 1629-1632
8. Bryszewska M., Watala C., Torzecka W. (1986): Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes. Br. J. Haematol. 62, 111-116
9. Bryszewska M., Zavodnik I. B., Niekurzak A., Szosland K. (1995): Oxidative processes in red blood cells from normal and diabetic individuals. Biochem. Mol. Biol. Int. 37, 345-354
10. Caimi G., Serra A., Lo Presti R. Montana M., Catania A., Sarno A. (1992): Erythrocyte membrane fluorescence parameters in diabetes mellitus. Diabetes Res. 21, 19-26
11. Candiloros H., Muller S., Zeghari N., Donner M., Drouin P., Ziegler O. (1995): Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Diabetes Care 18, 549-551
12. Čársky J., Lazarová M., Beňo A. (1978): Study of β-resorcylidene aminoguanidine. I. Spectral and acid-basic properties of the onium compounds. Acta F. R. N. Univ. Comen. Chimia 26, 89-102
13. Čársky J., Beňo A., Lazarová M. (1980): Spectrophotometric study of reaction of copper (II) with resorcylaldehyde aminoguanidine. Acta F. R. N. Univ. Comen. Chimia 28, 77-83
14. Fedunová D., Antalík M. (1998): Studies on interactions between metmyoglobin and heparin. Gen. Physiol. Biophys. 17, 117-131
15. Gennis R. B. (1989): Membrane dynamics ad protein-lipid interactions. In: Biomembranes. Molecular Structure and Function., pp. 166-198, Springer-Verlag, New York
16. Hanahan D. J., Ekholm J. E. (1974): The preparation of red cell ghosts (membranes). In: Methods in Enzymology (Eds. S. Fleischer, L. Packer), vol. 31, pp. 168-172, Academic Press, New York
17. Hill M. A., Court J. M. (1983): Erythrocyte membrane fluidity in type 1 diabetes mellitus. Pathology 15, 449-451
18. Hrnčiarová M., Čársky J., Jakuš V., Zlatoš L., Kucharská J., Gvozdjáková A. (1998): Inhibition of erythrocyte lipid peroxidation in diabetic rats by aminoguanidine, resorcylidene aminoguanidine and their oxygen and sulphur analogs. Bratisl. Lek. Listy 99, 364-367
19. Ivanov I. T. (1999): Changes in passive electric parameters of human erythrocyte membrane during hyperthermia: role of spectrin phosphorylation. Gen. Physiol. Biophys. 18, 165-180
20. Jakuš V., Hrnčiarová M., Čársky J., Krahulec B., Rietbrock N. (1999): Inhibition of non-enzymatic glycation and lipid peroxidation by drugs with antioxidant activity. Life Sci. 65, 1991-1993
21. Juhan-Vague I., Rahmani-Jourdheuil D., Mishal Z., Roul C., Mourayre Y., Aillaud M. F., Vague P. (1986): Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type 1 (insulin-dependent) diabetic patients. Diabetologia 29, 417-420
22. Lowry O. H., Rosebrough N. J., Farr A. L., Randall, R. J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
23. McMillan D. E. (1990): The role of blood flow in diabetic vascular disease. In: Diabetes Mellitus: Theory and Practice (Eds. H. Rifkin, D. Porte Jr.), pp. 234-248, Elsevier, New York
24. Onuska K. D., Čársky J., Lahitová K. (1996): Antimutagenic and bacteriostatic activities of Schiff base compounds derived from aminoguanidine, semicarbazone and thiosemicarbazone and a copper (II) - coordination complex. J. Toxicol. Environ. Chem. 57, 163-170
25. Plášek J., Jarolím P. (1987): Interaction of the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene with biomembranes. Gen. Physiol. Biophys. 6, 425-437
26. Shinitzky M. (1984): Membrane fluidity and cellular functions. In: Physiology of membrane Fluidity (Ed. M. Shinitzky), vol. 1, pp. 1-52, Boca Raton, FL: CRC
27. Shinitzky M., Barenholz Y. (1978): Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys. Acta 515, 367-394
28. Šikurová L., Mateašik A., Ruttkay-Nedecký G. (1998): Receptor destroying enzyme disturbs erythrocyte membrane ordering. Pharmazie 53, 726-727
29. Šikurová L., Dérerová J., Kvasnička P., Waczulíková I., Čársky J., Uličná O. (2000): Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus. Pharmazie 55, 700-701
30. Sills R. H., Moore D. J., Mendelsohn R. (1994): Erythrocyte peroxidation: quantitation by Fourier transform infrared spectroscopy. Anal. Biochem. 218, 118-123
31. Skamarauskas J. T., McKay A. G., Hunt J. V. (1996): Aminoguanidine and its pro-oxidant effect on an experimental model of protein glycation. Free Radical Biol. Med. 21, 801-812
32. Sugiyama T., Miyamoto K., Katagiri S. (1986): Fetal toxicity of aminoguanidine in mice and rats. J. Toxicol. Sci. 11, 189-195
33. Waczulíková I., Čársky J. (1997): Some physical parameters of biological membrane systems altered by resorcylidene aminoguanidine in respect to diabetes mellitus. In: Advances in Medical Physics, Biophysics and Biomaterials (Ed. E. Kukurová) vol. I., pp. 36-39, Malé Centrum, Bratislava
34. Watala C. (1993): Altered structural and dynamic properties of blood cell membranes in diabetes mellitus. Diabet. Med. 10, 13-20
35. Watala C., Winocour P. D. (1992): The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects. Eur. J. Clin. Chem. Clin. Biochem. 30, 513-519
36. Watala C., Kordacka M., Loba A., Jóźwiak Z., Nowak S. (1987): Analysis of membrane fluidity alterations and lipid disorders in type I diabetic children and adolescents. Acta Diabetol. Lat. 24, 141-148
37. Watala C., Gwoździński K., Pluskota E., Pietrucha T., Walkowiak B., Trojanowski Z., Cierniewski C. S. (1996): Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets. Thromb. Haemost. 75, 147-153
38. Wolff S. P. (1996): Free radicals and glycation theory. In: The Maillard reaction: Consequences for the Chemical and Life Sciences (Ed. R. Ikan), pp. 73-88, John Wiley Sons Ltd
39. Zavodnik I. B., Piasecka A., Szosland K., Bryszewska M. (1997): Human red blood cell membrane potential and fluidity in glucose solutions. Scand. J. Clin. Lab. Invest. 57, 59-63
40. Ziegelhöffer A., Ravingerová T., Styk J., Šeboková J., Waczulíková I., Breier A., Džurba A., Volkovová K., Čársky J., Turecký L. (1997): Mechanisms that may be involved in calcium tolerance of diabetic heart. Mol. Cell. Biochem. 176, 191-198